Both in Pharmaceuticals
Valion Bio vs Nexentis Technologies
Over the past year VBIO returned −75.7% and NXTS returned −67.6%; their daily moves had a correlation of 0.08.
VBIO −75.7% NXTS −67.6%Growth of $1, one year, split-adjusted
| Metric | VBIO | NXTS |
|---|---|---|
| Price | $0.5499 | $0.5254 |
| Market cap | $1.2M | $763.6K |
| Today | +3.58% | −1.13% |
| 1 month | −77.8% | −61.9% |
| 6 months | — | — |
| Year to date | — | — |
| 1 year | — | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | -$5.3M | $8.5M |
| Dividend yield | — | — |
| Volatility (60d) | — | — |
| Short % of float | 9.0% | 2.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).